TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
KMDA

Kamada

Healthcare · Drug Manufacturers - Specialty & Generic

8.10$ +0.0% vs. previous close Closing price · As of: Nov 12, 2026

Statements

Income Statement

Kamada (KMDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Revenue" came in at 51 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement KMDA
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 LTM
36 38 42 42 39 44 45 47 45 45 55 51 196
22 21 24 25 22 23 26 27 28 26 32 28 114
14 17 19 17 17 21 19 20 17 19 22 23 81
3.2 4.3 4.8 3.4 2.7 4.2 3.2 2.6 2.9 2.2 2.2 2.3 9.6
7.7 3.8 3.8 4.0 8.8 4.2 4.1 4.8 11 5.2 5.8 – –
12 13 13 12 12 13 12 12 13 12 13 13 51
2.8 4.0 5.6 5.3 5.1 7.8 7.1 7.8 3.6 7.0 9.5 10 30
0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.4 0.2 1.0
5.0 2.4 4.5 3.9 2.5 6.6 5.8 6.4 4.7 5.4 10 9.5 30
0.0 0.1 0.1 0.1 -1.3 2.6 -1.6 1.1 1.2 1.3 0.9 1.7 5.0
5.1 2.4 4.4 3.9 3.8 4.0 7.4 5.3 3.6 4.1 9.3 7.8 25
8.2 5.8 7.9 7.4 6.7 10 9.7 10 8.8 9.4 13 14 46

LTM = last twelve months (sum of the four most recent quarters).

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?